# FDA Inspection 1166836 - Laila Arash-Kaps, M.D. - April 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/laila-arash-kaps-md/33d19e9d-6fad-49eb-88f7-cd87241d58c0
Source feed: FDA_Inspections

> FDA Inspection 1166836 for Laila Arash-Kaps, M.D. on April 07, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166836
- Company Name: Laila Arash-Kaps, M.D.
- Inspection Date: 2022-04-07
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1134615 - 2020-11-06](https://www.keypedia.com/records/fda_inspections/laila-arash-kaps-md/f3870694-222f-443f-88b4-4d50ab0899f8)

Company: https://www.keypedia.com/companies/laila-arash-kaps-md/d6c800cb-1e4c-4d11-9d45-4be8e918b35e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c